Correction: Ubiquitin B: an essential mediator of trichostatin A-induced tumor-selective killing in human cancer cells (Cell Death & Differentiation, (2010), 17, 1, (109-118), 10.1038/cdd.2009.142);Ubiquitin B: An essential mediator of trichostatin A-induced tumor-selective killing in human cancer cells

Cell Death and Differentiation

Volumn 17, Issue 1, 2010, Pages 109-118

  Wu, P ^a   Tian, Y ^a   Chen, G ^a   Wang, B ^a   Gui, L ^a   Xi, L ^a   Ma, X ^a   Fang, Y ^a   Zhu, T ^a   Wang, D ^a   Meng, L ^a   Xu, G ^a   Wang, S ^a   Ma, D ^a   Zhou, J ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

apoptosis; histone deacetylase inhibitors; suppression of mortality by antisense rescue technique; ubiquitin B

Indexed keywords

APICIDIN; BCR ABL PROTEIN; CASPASE 3; CASPASE 9; CYTOCHROME C; PROTEIN BCL 2; PROTEIN MCL 1; TRICHOSTATIN A; UBIQUITIN; UBIQUITIN B; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; HISTONE DEACETYLASE INHIBITOR; HYDROXAMIC ACID; MYELOID CELL LEUKEMIA SEQUENCE 1 PROTEIN; SMALL INTERFERING RNA; UBB PROTEIN, HUMAN;

ANALYTIC METHOD; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL KILLING; CELL STRAIN K 562; CONTROLLED STUDY; CYTOSOL; ENZYME RELEASE; FEMALE; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENETIC IDENTIFICATION; GENETIC SCREENING; HELA CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LEUKEMIA CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; MORTALITY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SUPPRESSION OF MORTALITY BY ANTISENSE RESCUE TECHNIQUE; UBIQUITINATION; UPREGULATION; GENETICS; METABOLISM; PHYSIOLOGY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASE 3; CASPASE 9; CELL LINE, TUMOR; CYTOCHROMES C; HELA CELLS; HISTONE DEACETYLASE INHIBITORS; HUMANS; HYDROXAMIC ACIDS; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, SMALL INTERFERING; UBIQUITIN; UBIQUITINATION; UP-REGULATION;

EID: 77449097864     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/s41418-021-00829-5     Document Type: Erratum

References (33)

1. Carey N, La Thangue NB. Histone deacetylase inhibitors: gathering pace. Curr Opin Pharmacol 2006; 6: 369-375. (Pubitemid 44040838)
2. Bolden JE, Peart MJ, Johnstone RW. Anticancer activities of histone deacetylase inhibitors. Nat Rev Drug Discov 2006; 5: 769-784. (Pubitemid 44348499)
3. Marchion D, Munster P. Development of histone deacetylase inhibitors for cancer treatment. Expert Rev Anticancer Ther 2007; 7: 583-598. (Pubitemid 46690964)
4. Duvic M, Vu J. Vorinostat: a new oral histone deacetylase inhibitor approved for cutaneous T-cell lymphoma. Expert Opin Investig Drugs 2007; 16: 1111-1120. (Pubitemid 47074165)
5. Mariadason JM, Corner GA, Augenlicht LH. Genetic reprogramming in pathways of colonic cell maturation induced by short chain fatty acids: comparison with trichostatin A, sulindac, and curcumin and implications for chemoprevention of colon cancer. Cancer Res 2000; 60: 4561-4572. (Pubitemid 32103641)
6. Ungerstedt JS, Sowa Y, Xu WS, Shao Y, Dokmanovic M, Perez G et al. Role of thioredoxin in the response of normal and transformed cells to histone deacetylase inhibitors. Proc Natl Acad Sci USA 2005; 102: 673-678. (Pubitemid 40282724)
7. Kwon SH, Ahn SH, Kim YK, Bae GU, Yoon JW, Hong S et al. Apicidin, a histone deacetylase inhibitor, induces apoptosis and Fas/Fas ligand expression in human acute promyelocytic leukemia cells. J Biol Chem 2002; 277: 2073-2080. (Pubitemid 34968790)
8. Johnstone RW. Histone-deacetylase inhibitors: novel drugs for the treatment of cancer. Nat Rev Drug Discov 2002; 1: 287-299. (Pubitemid 37361445)
9. Mitsiades CS, Mitsiades NS, McMullan CJ, Poulaki V, Shringarpure R, Hideshima T et al. Transcriptional signature of histone deacetylase inhibition in multiple myeloma: biological and clinical implications. Proc Natl Acad Sci USA 2004; 101: 540-545. (Pubitemid 38084672)
10. Deiss L, Kimchi A. A genetic tool used to identify thioredoxin as a mediator of a growth inhibitory signal. Science 1991; 252: 117-120. (Pubitemid 21916950)
11. Hofmann ER, Boyanapalli M, Lindner DJ, Weihua X, Hassel BA, Jagus R et al. Thioredoxin reductase mediates cell death effects of the combination of beta interferon and retinoic acid. Mol Cell Biol 1998; 18: 6493-6504. (Pubitemid 28500539)
12. Bali P, Pranpat M, Bradner J, Balasis M, Fiskus W, Guo F et al. Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90: a novel basis for antileukemia activity of histone deacetylase inhibitors. J Biol Chem 2005; 280: 26729-26734. (Pubitemid 41040705)
13. Minucci S, Pelicci PG. Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer. Nat Rev Cancer 2006; 6: 38-51. (Pubitemid 43054973)
14. Qiu L, Burgess A, Fairlie DP, Leonard H, Parsons PG, Gabrielli BG. Histone deacetylase inhibitors trigger a G2 checkpoint in normal cells that is defective in tumor cells. Mol Biol Cell 2000; 11: 2069-2083. (Pubitemid 30408065)
15. Nenoi M. Induced accumulation of polyubiquitin gene transcripts in HeLa cells after UVirradiation and TPA-treatment. Int J Radiat Biol 1992; 61: 205-211.
16. Delic J, Morange M, Magdelenat H. Ubiquitin pathway involvement in human lymphocyte gamma-irradiation-induced apoptosis. Mol Cell Biol 1993; 13: 4875-4883. (Pubitemid 23220393)
17. Finch JS, St John T, Krieg P, Bonham K, Smith HT, Fried VA et al. Overexpression of three ubiquitin genes in mouse epidermal tumors is associated with enhanced cellular proliferation and stress. Cell Growth Differ 1992; 3: 269-278.
18. Ryu KY, Sinnar SA, Reinholdt LG, Vaccari S, Hall S, Garcia MA et al. The mouse polyubiquitin gene Ubb is essential for meiotic progression. Mol Cell Biol 2008; 28: 1136-1146. (Pubitemid 351160069)
19. Orlowski RZ. The role of the ubiquitin-proteasome pathway in apoptosis. Cell Death Differ 1999; 6: 303-313. (Pubitemid 29186874)
20. Schwartz LM, Myer A, Kosz L, Engelstein M, Maier C. Activation of polyubiquitin gene expression during developmentally programmed cell death. Neuron 1990; 5: 411-419. (Pubitemid 20369577)
21. Roy C, Brown DL, Little JE, Valentine BK, Walker PR, Sikorska M et al. The topoisomerase II inhibitor teniposide (VM-26) induces apoptosis in unstimulated mature murine lymphocytes. Exp Cell Res 1992; 200: 416-424.
22. Kramer OH, Muller S, Buchwald M, Reichardt S, Heinzel T. Mechanism for ubiquitylation of the leukemia fusion proteins AML1-ETO and PML-RARalpha. FASEB J 2008; 22: 1369-1379. (Pubitemid 351656778)
23. Kramer OH, Zhu P, Ostendorff HP, Golebiewski M, Tiefenbach J, Peters MA et al. The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2. EMBO J 2003; 22: 3411-3420. (Pubitemid 36834871)
24. Rao R, Fiskus W, Yang Y, Lee P, Joshi R, Fernandez P et al. HDAC6 inhibition enhances 17-AAG-mediated abrogation of hsp90 chaperone function in human leukemia cells. Blood 2008; 112: 1886-1893.
25. Duus J, Bahar HI, Venkataraman G, Ozpuyan F, Izban KF, Al-Masri H et al. Analysis of expression of heat shock protein-90 (HSP90) and the effects of HSP90 inhibitor (17-AAG) in multiple myeloma. Leuk Lymphoma 2006; 47: 1369-1378. (Pubitemid 44269648)
26. Rahmani M, Reese E, Dai Y, Bauer C, Kramer LB, Huang M et al. Cotreatment with suberanoylanilide hydroxamic acid and 17-allylamino 17- demethoxygeldanamycin synergistically induces apoptosis in Bcr-Abl+ Cells sensitive and resistant to STI571 (imatinib mesylate) in association with down-regulation of Bcr-Abl, abrogation of signal transducer and activator of transcription 5 activity, and Bax conformational change. Mol Pharmacol 2005; 67: 1166-1176. (Pubitemid 40416722)
27. Fotheringham S, Epping MT, Stimson L, Khan O, Wood V, Pezzella F et al. Genome-wide loss-of-function screen reveals an important role for the proteasome in HDAC inhibitorinduced apoptosis. Cancer Cell 2009; 15: 57-66.
28. Yan X, Fraser M, Qiu Q, Tsang BK. Over-expression of PTEN sensitizes human ovarian cancer cells to cisplatin-induced apoptosis in a p53-dependent manner. Gynecol Oncol 2006; 102: 348-355. (Pubitemid 44063583)
29. Rajan S, Cacalano G, Bryan R, Ratner AJ, Sontich CU, van Heerckeren A et al. Pseudomonas aeruginosa induction of apoptosis in respiratory epithelial cells: analysis of the effects of cystic fibrosis transmembrane conductance regulator dysfunction and bacterial virulence factors. Am J Respir Cell Mol Biol 2000; 23: 304-312.
30. Wu P, Meng L, Wang H, Zhou J, Xu G, Wang S et al. Role of hTERT in apoptosis of cervical cancer induced by histone deacetylase inhibitor. Biochem Biophys Res Commun 2005; 335: 36-44. (Pubitemid 41350760)
31. Hirt B. Selective extraction of polyoma DNA from infected mouse cell cultures. J Mol Biol 1967; 26: 365-369.
32. Heerdt BG, Houston MA, Mariadason JM, Augenlicht LH. Dissociation of staurosporineinduced apoptosis from G2-M arrest in SW620 human colonic carcinoma cells: initiation of the apoptotic cascade is associated with elevation of the mitochondrial membrane potential (deltapsim). Cancer Res 2000; 60: 6704-6713.
33. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(Delta Delta C(T)) Method. Methods 2001; 25: 402-408. (Pubitemid 34164012)